Physician profile
Danny Kewson
NPI 1659351872
$3,705.67
in general payments reported to CMS, 2019-2025
20 companies · $432 in 2025
The $432 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $58.15 · 2021: $423 · 2022: $481 · 2023: $615 · 2024: $268 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $951.93 | 2019 | |
| Medtronic, INC. | $587.05 | 2022-2024 | Propel, Sinuva, Nuvent |
| Intersect Ent, INC. | $487.91 | 2021-2022 | |
| Acclarent, INC | $323.13 | 2019-2024 | Acclarent Aera, Acclarent Navwire |
| Regeneron Healthcare Solutions, INC. | $280.32 | 2019-2025 | Dupixent |
| Stryker Corporation | $224.22 | 2019-2022 | |
| Integra Lifesciences Corporation | $143.52 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Genzyme Corporation | $138.87 | 2019-2025 | |
| Cochlear Americas | $106.61 | 2019 | |
| Optinose US, INC. | $93.98 | 2019-2025 | |
| Baxter Healthcare | $92.40 | 2022 | |
| Aerin Medical INC. | $83.13 | 2024-2025 | |
| Glaxosmithkline, LLC. | $39.03 | 2019-2025 | Nucala |
| Greer Laboratories, INC. | $35.33 | 2025 | Palforzia |
| Kaleo, INC. | $29.13 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xoran Technologies LLC | $21.20 | 2021 | |
| Hologic Sales and Service, LLC | $20.21 | 2025 | Coolseal Generator |
| Alk-Abello, INC | $18.09 | 2020 | |
| Ethicon US, LLC | $16.20 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal |
| Checkpoint Surgical, INC | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Kewson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.